血小板缺血和心房患者的不良结果之间的相关性:系统性审查和元分析
Qiuhua Ding1, Wenlin Xu1, Yaoyao Chen1
1Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Frontiers in cardiovascular medicine
|December 18, 2024
概括
在心房患者的血小板缩降低了中风风险,但增加了严重出血和死亡率. 仔细管理低血小板计数对于改善结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 临床研究 临床研究
背景情况:
- 血栓缩是心房动患者不良事件的已知危险因素.
- 了解血小板缺血对结果的具体影响对于患者管理至关重要.
研究的目的:
- 进行一项元分析,评估血小板缺血对缺血性中风/全身栓塞,严重出血和心房患者全因死亡率的影响.
- 为了提供一个全面的概述,与血小板缺血在这个人群中相关的风险.
主要方法:
- 在PubMed和Web of Science数据库中的系统文献搜索,截至2023年12月1日.
- 用REVMAN 5.4软件对12项涉及73824名心房患者的研究进行了元分析.
- 评估研究质量和提取相关数据,包括赔率比率和置信区间.
主要成果:
- 患有血小板的心房患者显示,缺血性中风/全身血栓塞的风险降低 (OR:0.79,95% CI:0.69-0.91).
- 相反,血小板缺血与明显更高的严重出血风险 (OR: 1.51,95% CI: 1.20-1.79) 和所有原因死亡率 (OR: 1.40,95% CI: 1.23-1.61) 相关.
结论:
- 血小板缺血显著影响心房患者的预后.
- 虽然降低了中风风险,但血小板缺血增加了严重出血和死亡的风险,需要集中临床注意力和优化治疗策略.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
01:24Disorders of Hemostasis
699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
01:16Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
467
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
467
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K